News for LeMaitre Vascular, Inc. (LMAT)

Anteris Technologies (AVR) has appointed David Roberts and Gregory Moss to its Board of Directors, enhancing leadership with U.S.-based healthcare expertis

Conference Call Scheduled for today, May 15, 2025, at 5:00pm ET. GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. ( POCI)

**media[627631]**

LeMaitre Vascular (LMAT) to present at the Bank of America Securities 2025 Healthcare Conference. President David Roberts will lead the presentation sch

BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (LMAT) announced today that David Roberts, President, will present at the Bank of

**media[615192]**

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2025 Earnings Conference Call May 1, 2025 5:00 PM ETCompany ParticipantsDorian LeBlanc - CFOGeorge LeMaitre -...

LeMaitre (LMAT) reported impressive first-quarter revenue of $59.87 million, exceeding market expectations of $57.61 million. The company's strong sales perform

Move expected to drive both top-line growth and gross margin improvement SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. ( ELUT) (”œElutia

Revenue: $59.9 million, surpassing the estimated $57.64 million, with a 12% year-over-year increase.EPS: $0.48, slightly below the estimated $0.50, yet reflect

LeMaitre Vascular Inc (LMAT) reported a 14% revenue increase, but missed analysts' expectations by 0.7%. Post-earnings, the stock plummeted 19.7%, despi

**media[583165]**

Shares of LeMaitre Vascular Inc (LMAT) fell 2.56% in mid-day trading on Mar 22. The stock reached an intraday low of $82.52, before recovering slightly to $83

GARDNER, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. ( POCI), a leading designer and manufacturer of advanced optical instrum

On March 4, 2025, Lawrence Jasinski, Director at LeMaitre Vascular Inc (LMAT), sold 3,142 shares of the company, as reported in a SEC Filing. Following this tra

Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year This Appointment Rep

**media[556936]**

LeMaitre Vascular Inc (LMAT), a leading provider of devices and services for the treatment of peripheral vascular disease, announced on March 3, 2025, that its

BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upc